HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 66 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,593 | -32.0% | 13,513 | -33.7% | 0.00% | – |
Q2 2023 | $58,261 | -13.7% | 20,371 | -6.8% | 0.00% | – |
Q1 2023 | $67,532 | -56.4% | 21,855 | -70.2% | 0.00% | – |
Q4 2022 | $154,923 | -14.9% | 73,423 | +31.8% | 0.00% | – |
Q3 2022 | $182,000 | +2.8% | 55,712 | +0.8% | 0.00% | – |
Q2 2022 | $177,000 | -50.8% | 55,295 | +8.4% | 0.00% | – |
Q1 2022 | $360,000 | +13.6% | 50,998 | +16.5% | 0.00% | – |
Q4 2021 | $317,000 | – | 43,779 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
Sciencast Management LP | 26,300 | $182,000 | 0.04% |
Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |